Quidel | QDEL - Selling And Administration Expenses


Quidel reported $189.7M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Agilent USD 475M 10M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Bruker USD 238.9M 3.2M Jun/2026
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 228.9M 69.47M Jun/2026
Danaher USD 2.16B 87M Sep/2026
Haemonetics USD 118.94M 1.99M Jun/2026
Illumina USD 273M 1000K Jun/2026
IQVIA Holdings USD 569M 5M Sep/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Mettler Toledo International USD 263.33M 5.01M Jun/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Neogen USD 100.8M 1000K Jun/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Quidel USD 189.7M 9.6M Jun/2026
Revvity USD 278.58M 24.69M Jun/2026
STAAR Surgical USD 45.14M 6.5M Jun/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Waters USD 405M 11M Jun/2026